These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26228372)

  • 21. HCV/HIV Coinfection: A New Treatment Paradigm.
    Kwo PY; Agrawal S
    Gastroenterology; 2015 Jun; 148(7):1470-1. PubMed ID: 25935524
    [No Abstract]   [Full Text] [Related]  

  • 22. [Argentine consensus on hepatitis C 2013].
    Reggiardo MV; Tanno F; Mendizabal M; Galdame O
    Acta Gastroenterol Latinoam; 2014 Jun; 44(2):154-73. PubMed ID: 25199310
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genotype 1 superresponder treat for only 24 weeks].
    MMW Fortschr Med; 2005 Dec; 147(51-52):69. PubMed ID: 16402717
    [No Abstract]   [Full Text] [Related]  

  • 24. [Detection of hepatitis C virus RNA].
    Ohishi W; Chayama K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):214-8. PubMed ID: 15359795
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of acute hepatitis C-how to explain the differences?
    Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
    Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
    [No Abstract]   [Full Text] [Related]  

  • 26. Rethinking hepatitis C viral kinetics: Insights into host-virus interactions in 'difficult-to-treat' groups and implications for novel treatment approaches.
    Yeung E; Chung RT
    J Hepatol; 2005 Nov; 43(5):748-50. PubMed ID: 16171895
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coinfection with hepatitis C and B viruses with pre-C mutant].
    Lepilleur B; Schoeny M; Melin P
    Ann Biol Clin (Paris); 2003; 61(3):319-22. PubMed ID: 12805009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal dosage of ribavirin.
    Mangia A; Andriulli A
    Hepatology; 2010 Sep; 52(3):1174. PubMed ID: 20812365
    [No Abstract]   [Full Text] [Related]  

  • 29. Infection fighters. Hepatitis C--is a cure possible?
    TreatmentUpdate; 2005; 17(1):8-9. PubMed ID: 17225319
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No Time for Bullies in Hepatitis C Virus Therapy: Genotype 3 Conquered?
    Aghemo A; Colombo M
    Gastroenterology; 2016 May; 150(5):1241-1243. PubMed ID: 27018182
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
    Urganci N; Gulec S; Dogan S; Nuhoglu A
    Int J Infect Dis; 2006 Nov; 10(6):453-7. PubMed ID: 17000127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the role of sofosbuvir in treating hepatitis C infection?
    Carey L
    JAAPA; 2015 Feb; 28(2):16-9. PubMed ID: 25621961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 36. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. I favor therapy for hepatitis C virus recurrence after transplantation.
    Samuel D
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S55-8. PubMed ID: 12362300
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel therapies in Hepatitis C virus. Preface.
    Pockros PJ
    Clin Liver Dis; 2009 Aug; 13(3):xiii. PubMed ID: 19628152
    [No Abstract]   [Full Text] [Related]  

  • 39. Decade in review-HCV: hepatitis C therapy-a fast and competitive race.
    Zeuzem S
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):644-5. PubMed ID: 25223875
    [No Abstract]   [Full Text] [Related]  

  • 40. Co-infections. Predicting recovery from hep C.
    TreatmentUpdate; 2008; 20(4):10-1. PubMed ID: 19248276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.